Quebec SEAO #20182498

Santé Québec Bas-Saint-Laurent Chemolock Drug Transfer Devices

Santé Québec Bas-Saint-Laurent plans to acquire Chemolock closed-system devices for hazardous-drug handling. - Buyer: Santé Québec, Bas-Saint-Laurent. - OEM and intended supplier: ICU Medical; ICU Medical Canada Inc. is identified as the intended supplier and the only supplier the agency says meets its requirements. - Product requested: ICU Medical Chemolock closed-system drug transfer devices; quantity and part number are not specified. - Key requirements: Dry, needleless membrane-to-membrane connections supporting up to 70 connections; leak-proof connectors that automatically stop flow when disconnected; secure connections resistant to accidental separation; and easy assembly without rotational movement. - Support primary-mode administration without secondary tubing, plus dry, secure disconnection and an integrated setup without extra adapters or extensions. - Compatible with Luer Lock products under the CAG contract, including syringes and Baxter Spectrum IQ and Novum IQ tubing; support effective flushing between potentially incompatible medications and align with pharmacy-preparation devices. - Health Canada approval required; components must be free of latex, PVC, BPA, and DEHP. - Contract term: 24 months, with one 12-month renewal option (up to 36 months total).

Description

Santé Québec Bas-Saint-Laurent intends to acquire closed-system drug transfer devices to meet ASSTSAS (2021) and NIOSH recommendations. The devices are intended to support the preparation and administration of hazardous drugs while reducing accidental exposure, environmental contamination, and waste. The notice states that ICU Medical Canada Inc. is the only supplier identified as able to meet the stated technical requirements, and announces an intended non-competitive award under section 13(4) of the LCOP. The planned contract term is 24 months, with one 12-month renewal option.

View original listing